Sector Expert: John Savin

Edison Investment Research



Recent Quotes

"Sales for CYTX's Celution device were $7.1M in FY/13."

— John Savin, Edison Investment Research (3/20/14)
more >

"CYTX's phase 2 trial of Athena could lead to a partnership deal in 2015."

— John Savin, Edison Investment Research (2/4/14)
more >



Due to permission requirements, not all quotes are shown.